B

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

Retrieved on: 
Friday, November 10, 2023
Hepatology, Safety, DNA, SAN, Therapy, PEI, HBsAg, AASLD, Emory University, Liver, Week, Doctor of Philosophy, B, CccDNA, Liver cancer, Hepatitis B virus, CHB, Entecavir, MBA, University, Hepatitis, Hong Kong, Physician, Poster, ETV, RNA, Vaccine, Pharmaceutical industry, HBeAg, Boston, New York University, Gastroenterology, Jacob Aligo

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that emerging hepatitis B antigen lowering data for its capsid assembly modulator – empty (CAM-E) drug, ALG-000184, are available as a late breaking poster at The Liver Meeting® of the American Association for the Study of Liver Diseases (AASLD), being held in Boston, Massachusetts, November 10 – 14, 2023.

Key Points: 
  • The data will be presented by Dr. Man-Fung Yuen, Chair and Professor of Gastroenterology and Hepatology at the University of Hong Kong, in Poster Hall C on Monday November 13 from 1-2 pm ET.
  • “ALG-000184 appears to have best-in-class antiviral properties which are also unique compared to other drug classes being evaluated for the treatment of chronic hepatitis B (CHB).
  • If the trends observed to date continue, ALG-000184 has the potential to become a cornerstone therapy in the treatment of CHB.
  • The antiviral effects of ALG-000184 presented at AASLD indicate that this drug is achieving significant viral suppression, likely via inhibition of cccDNA synthesis.

Welcome to attend MAG Interactive AB (publ) Annual General Meeting

Retrieved on: 
Thursday, December 7, 2023
Motivation, Social Security, Acquisition, Employment, Euroclear, MAG, SEK, Bank statement, Exercise, Drottninggatan, B, Annual report, MAG Interactive, AGM, Proxy, Person, PO, PwC, Loss, NMO, Name, Welfare, Security (finance), Auction, Financial adviser, Audit, Bookkeeping, Management, Holding company, Property management, Life insurance

STOCKHOLM, Dec. 7, 2023 /PRNewswire/ -- MAG Interactive AB (publ) hereby gives notice of its annual general meeting to be held at MAG Interactive AB (publ)'s premises at Drottninggatan 95A, Stockholm, on Wednesday 17 January 2024 at 14:00 CET.

Key Points: 
  • STOCKHOLM, Dec. 7, 2023 /PRNewswire/ -- MAG Interactive AB (publ) hereby gives notice of its annual general meeting to be held at MAG Interactive AB (publ)'s premises at Drottninggatan 95A, Stockholm, on Wednesday 17 January 2024 at 14:00 CET.
  • The personal data obtained from the share register maintained by Euroclear Sweden AB, the notification of participation at the annual general meeting and the information regarding proxies and assistants will be used for registration, preparation of the voting register for the annual general meeting and, where applicable, minutes from the annual general meeting.
  • Evelina Pettersson, PO Box 7358, SE-103 90 Stockholm, Sweden, well in advance of the annual general meeting.
  • Opening of the meeting and election of the chairman of the annual general meeting.

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Retrieved on: 
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes

The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.

Key Points: 
  • The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
  • With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
  • B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
  • Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

Retrieved on: 
Wednesday, November 1, 2023
Digital, Ageing, PN, Prickle (protein), Life, Prevalence, Burning Sensations, Diabetes, DPN, Artificial intelligence, Hypoesthesia, Senior, Quality of life, Somatosensory system, Paresthesia, B, Patient, Diagnosis, Nerve, Dietary supplement, B vitamins, Health, Peripheral neuropathy

SINGAPORE, Nov. 1, 2023 /PRNewswire/ -- Ahead of World Diabetes Day 2023, P&G Health, makers of Neurobion, continued awareness efforts with an innovative #KnowtheSigns campaign to help consumers and healthcare professionals understand the connection between Diabetes and Pre-Diabetes with Peripheral Neuropathy (PN) and Vitamin B Deficiency for timely detection, treatment, and improved quality of life.

Key Points: 
  • SINGAPORE, Nov. 1, 2023 /PRNewswire/ -- Ahead of World Diabetes Day 2023, P&G Health, makers of Neurobion, continued awareness efforts with an innovative #KnowtheSigns campaign to help consumers and healthcare professionals understand the connection between Diabetes and Pre-Diabetes with Peripheral Neuropathy (PN) and Vitamin B Deficiency for timely detection, treatment, and improved quality of life.
  • With Diabetes Mellitus being the leading cause1 of PN, the increasing prevalence of PN is closely linked to the rise in the number of diabetic patients.
  • Symptoms of PN include numbness, tingling, prickling, and burning sensations in the hands and feet.
  • B vitamin deficiency and aging are other high-risk factors along with diabetes, leading to peripheral nerve damage.

Purity Woods Introduces Industry-Disrupting Organic Vitamin B Supplement

Retrieved on: 
Monday, October 9, 2023
Health, Multimedia, Fire, Herbicide, Diet, Rest, Tree, Organic, DV, B, Vitamin B12 deficiency, USDA, Consumer Reports, Ageing, Organic certification, Longevity, The Non-GMO Project, Meat, Pesticide, Dietary supplement, Agriculture

GENEVA, Ill., Oct. 9, 2023 /PRNewswire-PRWeb/ -- 40% of the U.S. population may be low in B12, and that number is even higher among plant-based eaters and older adults. B12 is essential for many functions, including brain health, healthy energy levels, and heart health.

Key Points: 
  • Purity Woods has launched ORGANIC B COMPLETE, a USDA Certified Organic vitamin B complex supplement.
  • Seeing a massive gap in the market for a highly effective vitamin B complex that was also truly USDA Certified Organic and safe, Purity Woods is thrilled to announce an exciting expansion into supplements with the new ORGANIC B COMPLETE.
  • The USDA Certified Organic Organic B Complete is meticulously crafted from organic whole food ingredients to provide a complete blend of all eight essential B vitamins.
  • Seeing this need for a highly effective and independently verified organic vitamin B supplement, Purity Woods created Organic B Complete.

Bonds at a premium: the impact of insurers on corporate bond issuers

Retrieved on: 
Friday, September 29, 2023
Insurance, Becker, European Central Bank, Emirates Institute for Banking and Financial Studies, Journal of Political Economy, Jose Pablo Cantillo, Central bank, Political economy, Review, American Economic Review, St. Louis Fed Financial Stress Index, KZ, Magazine, Pierce, Research, USD, RESEARCH, Financial economics, Journal, Directorate, Nature, Monetary economics, ECB, Corporation, Working paper, Federal Reserve Economic Data, Jensen, Efficiency, FRED, Annual Review of Financial Economics, B, Journal of Monetary Economics, The Review of Financial Studies, Security (finance), Bank, Bookkeeping, Financial adviser, Financial services, Textile, Cryptocurrency
Key Points: 

Insider Named a Leader in the IDC MarketScape: Worldwide Omnichannel Marketing Platforms for B2C Enterprises 2023

Retrieved on: 
Thursday, September 28, 2023
Omni, IDC, WhatsApp, Analytics, Virginity, AMP, Marketing, Integration, Omnichannel, Synthetic media, Vision, CX, Samsung, Research, AOV, SMS, GAP, Slazenger, Sirius, CNN, NPS, MAC, Singapore Airlines, Allianz, B, Marks & Spencer, CRM, Loyalty, Cosmetics, MAC Cosmetics, Entrepreneurship, Growth, AI, ROI, Coca-Cola, Burger King, Commerce, Mobile phone, Sales, Retail, Insider, Adidas, Lenovo, Vodafone

NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Insider, one platform for building individualized, cross-channel customer experiences, today announced it has been named as a Leader in the IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023 Vendor Assessment (doc #US49727423, August 2023).

Key Points: 
  • NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Insider , one platform for building individualized, cross-channel customer experiences, today announced it has been named as a Leader in the IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023 Vendor Assessment (doc #US49727423, August 2023).
  • The first-ever IDC MarketScape report on Omnichannel Marketing Platforms covers 14 worldwide Omnichannel Marketing vendors based on their product capabilities and market strategy.
  • The IDC MarketScape recognizes Insider as a Leader, noting that it "supports an impressive array of multichannel marketing tactics including email, marketing, website personalization, push notifications, and in-app messaging."
  • Read the report excerpt to find out why Insider has been named a Leader by the IDC MarketScape.

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Friday, September 8, 2023
Mesotherapy, Nicotinamide, Rejuvenation, Lysine, Skin care, Biotin, Epidermis, Multimedia, Absorption, Dicarboxylic acid, Cofactor, Vitamin, Protein, CH, Histidine, B, Skin, Arginine, Dietary supplement, Online shopping

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Friday, September 8, 2023
Mesotherapy, Nicotinamide, Rejuvenation, Lysine, Skin care, Biotin, Epidermis, Absorption, Dicarboxylic acid, Cofactor, Vitamin, Protein, CH, Histidine, B, Skin, Arginine, Dietary supplement

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

Prosus N.V.: Notice of Hybrid Annual General Meeting and Cash Dividend Declaration

Retrieved on: 
Wednesday, July 12, 2023
Retail, Publishing, Technology, Finance, Fintech, Education, Communications, Training, Professional Services, Online Retail, Other Retail, Electronic Commerce, Other Technology, Delivery Services, Internet, Annual general meeting, Repurchase agreement, Annual, JSE, N, AEX, B, Annual report, Articles of association, The Warehouse Group, A1, Holding company, Security (finance), Management, Cryptocurrency, Naspers, Prosus

Prosus N.V. (Prosus) (AEX and JSE: PRX): Prosus shareholders are advised that notice is hereby given, in terms of the notice of annual general meeting published today, on 12 July 2023, that the hybrid annual general meeting of Prosus (the Annual General Meeting) will be held at 14:00 CET on Wednesday, 23 August 2023, at The Warehouse, Generaal Vetterstraat 51-A, 1059 BT Amsterdam, the Netherlands.

Key Points: 
  • Prosus N.V. (Prosus) (AEX and JSE: PRX): Prosus shareholders are advised that notice is hereby given, in terms of the notice of annual general meeting published today, on 12 July 2023, that the hybrid annual general meeting of Prosus (the Annual General Meeting) will be held at 14:00 CET on Wednesday, 23 August 2023, at The Warehouse, Generaal Vetterstraat 51-A, 1059 BT Amsterdam, the Netherlands.
  • Prosus will, in any event, ensure virtual access to the Annual General Meeting in a manner consistent with the arrangements for a virtual meeting.
  • Prosus shareholders registered in the Prosus shareholders’ register or in the (sub)registers designated by the board of directors of Prosus (the Prosus Board) on Wednesday, 26 July 2023 (i.e.
  • Prosus shareholders are advised that further information pertaining to the Proposed Transaction in relation to Prosus is set out in the Shareholder Circular that Prosus has published today, on 12 July 2023, simultaneously with the notice of Annual General Meeting, on Prosus’ website at www.prosus.com/investors/shareholder-centre/shareholder-meetings .